selects SyntheZyme for Phase I SBIR
NY, January 11, 2010 – SyntheZyme LLC, a leading developer
of bioplastic monomers today announced that it has been
awarded by NSF a Phase I SBIR for approximately $150,000
from NSF to develop biopesticides based on its proprietary
yeast enzyme technology.
Biobased and biodegradable industrial chemicals are at the
forefront of attaining sustainability in manufacturing and
agriculture. SyntheZyme addresses this need with
proprietary yeasts and separation technology to convert
natural oils and sugars into bioplastic monomers,
biopesticides and personal care product ingredients.
This grant focuses on the production and evaluation of a
number of natural lipid derivatives as antifungal agents to
protect crops and ornamental plants. “Biopesticides which
will not accumulate in the soil are the fastest growing
sector of the pesticide market. We expect to demonstrate
economical alternatives to synthetic fungicides with high
effectivity and rapid biodegradation” said Frank Shinneman,
SyntheZyme’s President & CEO.